Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status.
Brusa S, Terracciano D, Bruzzese D, Fiorenza M, Stanziola L, Pinchera B, Valente V, Gentile I, Cittadini A, Mormile I, Mormile M, Portella G.
Brusa S, et al. Among authors: gentile i.
Front Med (Lausanne). 2022 Nov 29;9:1034288. doi: 10.3389/fmed.2022.1034288. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36523781
Free PMC article.